⌘K

08:30:24·1502d

SECFilingvia Quantisnow

CorMedix Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.

CRMD· CorMedix Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

CRMD
CorMedix Inc.
Health Care

Recent analyst ratings

Oct 20UpdateD. Boral Capital$14.00
Jun 30UpdateD. Boral Capital-
Jun 30UpdateH.C. Wainwright$20.00
Mar 7UpdateLeerink Partners$18.00
Jan 13UpdateD. Boral Capital$15.00
Aug 26UpdateRodman & Renshaw$13.00

Related

SEC1d
SEC Form DEFA14A filed by CorMedix Inc.
SEC1d
SEC Form DEF 14A filed by CorMedix Inc.
SEC4d
CorMedix Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
PR4d
CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients
SEC13d
SEC Form PRE 14A filed by CorMedix Inc.
PR24d
CorMedix to Participate in Needham Virtual Healthcare Conference
SEC35d
Amendment: SEC Form SCHEDULE 13G/A filed by CorMedix Inc.
SEC55d
CorMedix Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits